Argentine Journal of Cardiology最新文献

Implication of Left Main Coronary Artery Disease on Coronary Artery Bypass Graft Surgery Results 冠状动脉左主干病变对冠状动脉搭桥手术结果的影响

Argentine Journal of Cardiology Pub Date : 2021-10-02 DOI: 10.7775/RAC.88.6.19102

G. Vaccarino, R. Melchiori, G. Bastianelli, Guillermo Gutierrez, J. Santucci, H. Fernández, A. Hita, J. Bonorino, J. Bilbao, S. Baratta

{"title":"Implication of Left Main Coronary Artery Disease on Coronary Artery Bypass Graft Surgery Results","authors":"G. Vaccarino, R. Melchiori, G. Bastianelli, Guillermo Gutierrez, J. Santucci, H. Fernández, A. Hita, J. Bonorino, J. Bilbao, S. Baratta","doi":"10.7775/RAC.88.6.19102","DOIUrl":"https://doi.org/10.7775/RAC.88.6.19102","url":null,"abstract":"Introduccion: La cirugia de revascularizacion miocardica (CRM) ha sido el abordaje indicado para el tratamiento de la lesion del tronco de la coronaria izquierda (TCI), siendo la angioplastia coronaria (ATC) un tratamiento alternativo en un grupo muy seleccionado de pacientes. Sin embargo, los criterios de no inferioridad de los resultados de la ATC en terminos de mortalidad e infarto de miocardio (IAM) en el seguimiento a mediano plazo es tema de discusion actual. Objetivo: Evaluar las caracteristicas clinicas, funcionales y angiograficas de los pacientes sometidos a CRM con y sin TCI, y las implicancias de morbimortalidad halladas. Material y metodos: Se sometio a 458 pacientes consecutivos a CRM; 187 (40.82%) presentaban TCI. El grupo con TCI tenia un perfil de riesgo mayor: ArgenScore: 2.78 (1.55-5.9) vs 2.78 (1.95-7) p=0.03, STS score: 0.85 (0.55-1.8) vs 0.77 (0.5-1.17) p=0.01 y EuroSCORE II: 2.2 (1.35-3.97) vs 1.75 (1.08-2.9) p=0.04 respecto al grupo sin TCI. Resultados: A pesar del mayor riesgo esperado no hubo diferencias estadisticamente significativas en mortalidad 3.2% vs 1.1%, IAM 2.6% vs 1.1% y ACV 1% vs 0.3% en los dos grupos. En el analisis multivariado el TCI no fue predictor de morbi-mortalidad (HR = 2.1; IC 95% 0.70-6.23; p = 0.18) e identifico positivamente a la fraccion de eyeccion preoperatoria (HR = 0.96; IC 95%: 0.93-0.99; p = 0.040) y la cirugia no programada (HR = 3.44; IC 95%: 1.60-7.41; p = 0.002). Conclusiones: en nuestra experiencia los pacientes intervenidos con CRM el TCI no es predictor de muerte, IAM y/o ACV.","PeriodicalId":447734,"journal":{"name":"Argentine Journal of Cardiology","volume":"100 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132146238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Trombosis del stent y COVID-19

Argentine Journal of Cardiology Pub Date : 2021-08-02 DOI: 10.7775/RAC.88.6.19393

Fernando G. Chiminela, Guillermo Jubany, E. Zaidel, Betiana Martin, Marcelo Bettinotti, L. C. Sztejfman

引用次数: 0

Aneurisma de arteria renal con estenosis bilateral de arteria renal

Argentine Journal of Cardiology Pub Date : 2021-08-02 DOI: 10.7775/RAC.88.6.18286

Jorge Goral, Osvaldo A. Barbosa, Mercedes Vizgarra, Pamela Wieresz, Cecilia Montiveros, Guillermina Forte

引用次数: 0

Rapid diagnosis of acute myocardial infarction 急性心肌梗死的快速诊断

Argentine Journal of Cardiology Pub Date : 2021-08-02 DOI: 10.7775/RAC.88.6.19476

P. L. Ayala, S. Shrestha, C. Mueller

{"title":"Rapid diagnosis of acute myocardial infarction","authors":"P. L. Ayala, S. Shrestha, C. Mueller","doi":"10.7775/RAC.88.6.19476","DOIUrl":"https://doi.org/10.7775/RAC.88.6.19476","url":null,"abstract":"Over the last decade, intense collaboration between physician scientists and the diagnostic industry has enabled game-changing innovation in the rapid diagnosis of acute myocardial infarction (AMI). (1–12) High sensitivity cardiac troponin (hs-cTn) assays enable reliable measurement of cardiac troponin (cTn) concentrations in the normal range, thereby increasing substantially the diagnostic accuracy for AMI already with the first blood drawn at presentation to the emergency department (ED). (1–12) This was a prerequisite for the development and maturation of early rule-out and rulein strategies for AMI into clinical practice worldwide. While the first iteration was complex and required the combination of a biomarker panel, the electrocardiogram, and a clinical risk score, allowing the safe ruleout of AMI in only 10% of patients with acute chest pain, the latest iterations including the European Society of Cardiology (ESC) 0/1h-algorithm are simple, as they are based on hs-cTn concentrations only, and allow the safe rule-out AND/OR rule-in of AMI in about 75% of patients. (13-21) The ESC 0/1h-algorithm is a combination of the single measurement approach with the original 0/1halgorithm. (5, 7, 22–25) It has all the advantages of the single measurement approach (speed and simplicity), but further extends the number of patients eligible for triage towards rule-out of AMI to those patients with low hs-cTnT/I concentrations at presentation and NO relevant change (rise AND/OR fall) in hs-cTnT/I concentrations after 1 h. It also adds the possibility to triage patients towards rule-in of AMI using high initial hs-cTnT/I concentrations and/or relevant changes in hs-cTnT/I after 1 h. The ESC 0/1h-algorithm has been derived and validated for all currently available hs-cTnT/I assays, with unique data-driven cut-off values for each assay to achieve a sensitivity and negative predictive value of 99% or higher. (5, 7, 22–26) It is recommended by the ESC guideline for the management of acute coronary syndromes in patients without","PeriodicalId":447734,"journal":{"name":"Argentine Journal of Cardiology","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127516051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Insuficiencia cardíaca por fístula arteriovenosa ilíaca externa posablación con láser de la vena safena 隐静脉激光消融后髂外动静脉瘘引起的心力衰竭

Argentine Journal of Cardiology Pub Date : 2021-08-02 DOI: 10.7775/RAC.88.6.18562

M. Parodi, Mariano Norese, Sergio Ferreyra Fernández, Yamil N. Ponce, José M. Escalante, G. Andersen

引用次数: 0

Clinical Characteristics and Cardiometabolic Control of Persons with Diabetes in the Cardiology Office in Argentina 阿根廷心脏病学办公室糖尿病患者的临床特征和心脏代谢控制

Argentine Journal of Cardiology Pub Date : 2021-08-02 DOI: 10.7775/RAC.88.6.18201

E. Forte, Carlos Buso, Paula Duczynski, A. L. Cobo, Paola Harwicz, M. Giorgi, E. Salmeri, Cesar Damian Berestein, A. Lescano, H. Sanabria

{"title":"Clinical Characteristics and Cardiometabolic Control of Persons with Diabetes in the Cardiology Office in Argentina","authors":"E. Forte, Carlos Buso, Paula Duczynski, A. L. Cobo, Paola Harwicz, M. Giorgi, E. Salmeri, Cesar Damian Berestein, A. Lescano, H. Sanabria","doi":"10.7775/RAC.88.6.18201","DOIUrl":"https://doi.org/10.7775/RAC.88.6.18201","url":null,"abstract":"Introduccion : La cardiologia tiene un rol protagonico en el control y el tratamiento de las personas con diabetes mellitus tipo2 (DM2). No contamos con datos epidemiologicos locales acerca de los pacientes con DM2 asistidos por la especialidad. Objetivos: Evaluar las caracteristicas clinicas, enfermedad cardiovascular (ECV) y tratamiento de personas con DM2 en el consultorio de cardiologia. Material y metodos: Se realizo un estudio observacional en 17 provincias de la Argentina durante 3 meses. Resultados: Se incluyeron 694 pacientes. La edad media fue de 64.7 ± 10.5 anos, con un tiempo de evolucion de la DM2 de10.7 ± 9.3 anos, indice de masa corporal de 32 ± 5,9 kg/m2, HbA1c de 7,3 ± 1,6 % y tension arterial 135/80 mmHg. El 70% delos pacientes presentaba 2 o mas factores de riesgo. El 48,1% presentaba ECV y el 40,9% enfermedad microvascular (31,4%nefropatia, 10,5% retinopatia, 8,3% neuropatia, 3,3% pie diabetico). El 57,3% se encontraban con antiagregantes, 84,3% con inhibidores del sistema renina/angiotensina/aldosterona (iECAS/ARAII), 79,5% con estatinas. Asimismo, el 85,9% recibia metformina, seguido de inhibidores de la dipeptidil peptidasa-4 (iDDP4) (24,1%), insulina (22,2%), sulfonilureas (SU) (14,3%),inhibidores del cotransportador sodio-glucosa tipo 2 (iSGLT2) (9,8%), agonistas del receptor glucagon like (arGLP1) (3%) yglitazonas (1,3%). El 55,9% tenia HbA1c < = 7%, 61,7% TA <140/90 mmHg, 58,5% LDL <100 mg/dl y 28,5% LDL <70 mg/dl.Conclusiones: La mayoria de los pacientes con DM2 presentaba dos o mas factores de riesgo cardiovasculares y una elevadaprevalencia de complicaciones asociadas. Observamos un bajo alcance de los objetivos terapeuticos, asi como tambien un bajo uso de farmacos con beneficio cardiovascular.","PeriodicalId":447734,"journal":{"name":"Argentine Journal of Cardiology","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126832941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Supradesnivelación persistente del segmento ST por infiltración miocárdica 心肌浸润导致ST段持续抬高

Argentine Journal of Cardiology Pub Date : 2021-08-02 DOI: 10.7775/RAC.88.6.19395

M. C. F. Gracia, José R. Ruiz Arroyo, Angel V. Tapia TIrado

引用次数: 0

Myocardial Involvement in Chagas disease: From Parasite to Immune Response 恰加斯病的心肌参与:从寄生虫到免疫反应

Argentine Journal of Cardiology Pub Date : 2021-05-26 DOI: 10.7775/RAC.89.2.20183

L. E. Echeverría

引用次数: 0

Impact of Cusp-Overlap Technique on Pacemaker Requirement after Transcatheter Aortic Valve Implantation 瓣尖重叠技术对经导管主动脉瓣植入术后起搏器需求的影响

Argentine Journal of Cardiology Pub Date : 2021-04-03 DOI: 10.7775/RAC.89.2.19091

M. Sztejfman, C. Giuliani, Sebastián Peralta, E. Zaidel, Luis Carlos Sztejfman, M. Bettinotti

{"title":"Impact of Cusp-Overlap Technique on Pacemaker Requirement after Transcatheter Aortic Valve Implantation","authors":"M. Sztejfman, C. Giuliani, Sebastián Peralta, E. Zaidel, Luis Carlos Sztejfman, M. Bettinotti","doi":"10.7775/RAC.89.2.19091","DOIUrl":"https://doi.org/10.7775/RAC.89.2.19091","url":null,"abstract":"Introduccion: Las bradiarritmias persistentes que requieren el implante de un marcapasos definitivo son una complicacionfrecuente tras el implante valvular aortico percutaneo (IVAP), pero un implante alto con tecnica Cusp-Overlap podria evitarlas alteraciones del sistema de conduccion.Objetivo: El objetivo fue determinar la tasa de uso de marcapasos en pacientes que recibieron IVAP con la tecnica convencionalcoplanar en comparacion con Cusp-Overlap.Material y metodos: Entre 2017 y 2019 se analizaron 65 pacientes consecutivos de dos centros, que recibieron valvulas Evolut-R o Evolut-Pro: 50 implante coplanar y 15 Cusp-Overlap.Resultados: La edad promedio era 80 anos y no hubo diferencias en el riesgo por puntaje EuroSCORE. Los procedimientos conla tecnica de Cusp-Overlap presentaron 0% de requerimiento de marcapasos en comparacion con 24,9% en el implante convencional(p = 0,041). Tambien hubo menos complicaciones mayores (6,67% vs 42%; OR = 0,09; IC 95% 0,01-0,8; p = 0,011).Conclusiones: En esta cohorte el IVAP con la tecnica de Cusp-Overlap se asocio con una necesidad de marcapasos nula. Dadoel potencial impacto a gran escala se necesita validar externamente los resultados obtenidos.","PeriodicalId":447734,"journal":{"name":"Argentine Journal of Cardiology","volume":"89 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130879535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Navigating in Bad Weather (Closing Speech of the 2020 SAC Academic Ceremony) 恶劣天气下的航行(2020年SAC学术典礼闭幕致辞)

Argentine Journal of Cardiology Pub Date : 2021-01-18 DOI: 10.7775/RAC.88.6.19477

Navarro Estrada, J. Luis

引用次数: 0